Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon.

Clinical and experimental rheumatology - 1 Jan 2000

Mazzaro C, Colle R, Baracetti S, Nascimben F, Zorat F, Pozzato G

Abstract excerpt

OBJECTIVE: Interferon is the first-choice therapy for HCV-positive mixed cryoglobulinemia, but only a small fraction of the patients show long-term recovery from the disease. In non-responders or relapsers, the second-line therapy (high dose interferon) generally is not effective. The aim of this study was to evaluate the effectiveness of leukocyte interferon as a second-line therapy in patients who are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Cryoglobulinemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Immunologic Factors

Share to Interferon-alpha

Share to Lymphoma, Non-Hodgkin

Share to Recurrence

Source

Identifiers

PMID: 11892704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon.PMID 11892704Read ↗

Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.Semantic proximity Read ↗

Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia.Semantic proximity Read ↗

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.Semantic proximity Read ↗

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.Semantic proximity Read ↗

Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.Semantic proximity Read ↗

Clinical and virological findings in mixed cryoglobulinaemia.Semantic proximity Read ↗

Hepatitis C virus risk: a hepatitis C virus related syndrome.Semantic proximity Read ↗

Hepatitis C virus infection and cryoglobulinaemia.Semantic proximity Read ↗

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?Semantic proximity Read ↗

Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?Semantic proximity Read ↗

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia.Semantic proximity Read ↗

Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.